The hard thing about something like Kogan is that every time you get some disappointing news, and the price plunges lower, you can rationalise it by saying that the news, while negative, is NOW more than reflected in the price, and that none of the issues are structural in nature. ie. they are short term issues that distract from a much more positive longer-term trend.
That might be true, and maybe this latest decline will prove to be a wonderful buying opportunity for longer term investors.
After all, revenues have more or less doubled in the last few years and despite the recent dip in quarterly gross sales, the business has grown sales by almost 20% per annum since Q3 FY20 (and maybe that's a fair period to benchmark things given the covid bump that was experienced in the prior year).
On the other hand, a lot of categories are going backwards -- even over a 2 year annualised basis (eg Advertising, mobile and third party brands). And if you strip out the Mighty Ape acquisition, gross sales have only grown at an annualised rate of 11% since Q3FY20.
On top of that, costs have increased substantially, such that the business is now loss making on an adjusted EBITDA basis. To be fair, a lot of these investments may not have yet had time to bear fruit, but it does underscore concerns over what operating margins look like at scale -- especially in the face of intense competition (Amazon), rising costs pressures and stagnating wages.
Let's annualise the latest quarterly gross sales numbers and apply an *underlying* net margin of 2%. That gives us NPAT of $21m, which puts shares on a PE of roughly 21. I'm not sure that's necessarily cheap for a business that is struggling to find growth (active customers were up only 3.6% yoy), especially in a rising interest rate environment.
Of course, perhaps they can resume sales growth and return to much healthier net margins. For example, we could assume FY gross sales of $1280m if we pro-rata the first 9 months of the year, and apply a 3.6% net margin (what they got on an underlying basis FY21). That'd give a FY *normalised* NPAT of $46m, and that would put shares on a forward PE of less than 10. Cheap!
I'm just not convinced they can deliver solid organic growth and achieve decent margins. Even if you assume 10% top line growth for the next few years, a 2% net margin and a PE of 16 -- you get a target price of just over $5, and that's an annual return of less than 10% from current prices.
This is not a business that is going to zero, far from it. I just find it hard to gain any real conviction and think the best days of growth are over. I think shares are, at best, around fair value.
I could well be wrong, and it's worth remembering that profit assumptions change a LOT if you apply a higher margin (eg if you assume a 3% net margin instead of a 2% one in my example above, you have a FY25 target price of $7.64! -- all else being equal)
So i get the Bull case, but it's just in the too hard basket for me.
You can read the recent quarterly update here